Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics

Luis D’Marco1, María Jesús Puchades1,2, María Romero-Parra1, José Luis Górriz1,2
1Hospital Clínico Universitario, Institute of Health Research (INCLIVA), Valencia, Spain
2Universidad de Valencia, Valencia, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Toniolo, 2019, The diabetes pandemic and associated infections, Rev Med Microbiol, 30, 1, 10.1097/MRM.0000000000000155

Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost, 16, 206, 10.1111/jth.14817

MacIntyre, 2020, On a knife's edge of a COVID-19 pandemic: is containment still possible?, Public Health Res Pract, 30, 3012000, 10.17061/phrp3012000

Guan, 2020, Clinical characteristics of Coronavirus disease 2019 in China, N Engl J Med, 1, 10.1101/2020.02.06.20020974

Gates, 2020, Responding to Covid-19 — a once-in-a-century pandemic?, N Engl J Med, NEJMp2003762, 10.1056/NEJMp2003762

Leung, 2020, Clinical features of deaths in the novel Coronavirus epidemic in China, Rev Med Virol, e2103, 10.1002/rmv.2103

Cheng, 2020, Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney Int, 97, 829, 10.1101/2020.02.18.20023242

Schoen, 2019, Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity, BMC Infect Dis, 19, 964, 10.1186/s12879-019-4592-0

Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabetic Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x

Banik, 2016, Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia, Virol Sin, 31, 81, 10.1007/s12250-015-3679-z

Zou, 2020, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front Med, 10.1007/s11684-020-0754-0

Danser, 2020, Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers, Hypertension, 10.1161/HYPERTENSIONAHA.120.15082

Vaduganathan, 2020, Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19, N Engl J Med, 382, 1653, 10.1056/NEJMsr2005760

Peng, 2020, [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV], Zhonghua Xin Xue Guan Bing Za Zhi, 48, E004, 10.3760/cma.j.cn112148-20200220-00105

Naicker, 2020, The novel Coronavirus 2019 epidemic and kidneys, Kidney Int, 97, 824, 10.1016/j.kint.2020.03.001

Li, 2020, Caution on kidney dysfunctions of 2019-nCoV patients, BMJ, 10.1101/2020.02.08.20021212